Quest Diagnostics Inc (DGX): Net Income
$992.00M
Year ended 2025-12-31
$1.06B
Trailing 12 months to 2026-06-30
+1.6%
3-year compound annual growth
-7.1%
5-year compound annual growth
+3.4%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $992.00M | +13.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $871.00M | +2.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $854.00M | -9.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $946.00M | -52.6% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $2.00B | +39.4% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $1.43B | +66.8% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $858.00M | +16.6% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $736.00M | -4.7% | 2021-02-22, From 2018-01-01 |
| 2017-12-31 | $772.00M | +19.7% | 2020-02-20, From 2017-01-01 |
| 2016-12-31 | $645.00M | -9.0% | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | $709.00M | +27.5% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $556.00M | -34.5% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $849.00M | +52.7% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $556.00M | +18.0% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $471.00M | -34.7% | 2014-02-18, From 2011-01-01 |
| 2010-12-31 | $720.89M | -1.1% | 2013-02-27, From 2010-01-01 |
| 2009-12-31 | $729.11M | +25.4% | 2012-02-16, From 2009-01-01 |
| 2008-12-31 | $581.49M | +71.1% | 2011-02-16, From 2008-01-01 |
| 2007-12-31 | $339.94M | n/a | 2010-02-17, From 2007-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $992.00M | +13.9% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $876.50M | +17.5% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | -$986.20M | n/m |
| Natera, Inc. (NTRA) | 2025-12-31 | -$208.16M | n/m |
| RadNet, Inc. (RDNT) | 2025-12-31 | -$18.65M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$416.28M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | -$68.09M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $66.35M | +174.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$21.35M | n/m |
Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗